Factors Which Predispose to the Onset of Autoimmune Disease. A Senior Honors Thesis

Similar documents
HORMONES AND DENDRITIC CELLS: INFLUENCES ON THE INITIATION OF THE AUTOIMMUNE DISEASE EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS DISSERTATION

PhD thesis. The role of complement in Experimental Autoimmune Encephalomyelitis, the mouse modell of Multiple Sclerosis

Potential Rebalancing of the Immune System by Anti-CD52 Therapy

B6/COLODR/SPL/11C/83/LAP/#2.006 B6/COLODR/SPL/11C/86/LAP/#2.016 CD11C B6/COLODR/SPL/11C/80/LAP/#2.011 CD11C

Supplemental Figure 1. Signature gene expression in in vitro differentiated Th0, Th1, Th2, Th17 and Treg cells. (A) Naïve CD4 + T cells were cultured

Relevant Disclosures

Supplemental Table I.

TITLE: Harnessing GPR17 Biology for Treating Demyelinating Disease

Supporting Information

Gender differences in CNS autoimmunity induced by mimicry epitope for PLP in SJL mice

The encephalitogenicity of TH17 cells is dependent on IL-1- and IL-23- induced production of the cytokine GM-CSF

Multiple Sclerosis and Neuroinflammation: Considering Gender differences to design therapeutic agents HALINA OFFNER

SUPPLEMENTARY INFORMATION

Interferon γ regulates idiopathic pneumonia syndrome, a. Th17 + CD4 + T-cell-mediated GvH disease

Early activation of CD4+ and CD8+ T lymphocytes by myelin basic protein in subjects with MS

Supplemental Materials for. Effects of sphingosine-1-phosphate receptor 1 phosphorylation in response to. FTY720 during neuroinflammation

IMMUNOTOOLS: EFFECT OF NOTCH-DEFICIENT MACROPHAGES TO AUTOIMMUNE DISEASE WIPAWEE WONGCHANA

Supplementary Figure S1. PTPN2 levels are not altered in proliferating CD8+ T cells. Lymph node (LN) CD8+ T cells from C57BL/6 mice were stained with

Regulatory functions of CD8 + CD28 T cells in an autoimmune disease model

Spleen. mlns. E Spleen 4.1. mlns. Spleen. mlns. Mock 17. Mock CD8 HIV-1 CD38 HLA-DR. Ki67. Spleen. Spleen. mlns. Cheng et al. Fig.

Autoimmunity. Autoimmunity arises because of defects in central or peripheral tolerance of lymphocytes to selfantigens

THE ROLE OF MIF PRODUCTION BY B LYMPHOCYTES IN EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS. Abigail E. Short

Supplementary Figure 1. Characterization of basophils after reconstitution of SCID mice

Primary oligodendropathy is not a trigger of CNS autoimmunity

effect on the upregulation of these cell surface markers. The mean peak fluorescence intensity

MATERIALS AND METHODS. Neutralizing antibodies specific to mouse Dll1, Dll4, J1 and J2 were prepared as described. 1,2 All

Blocking antibodies and peptides. Rat anti-mouse PD-1 (29F.1A12, rat IgG2a, k), PD-

Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression

NK cell flow cytometric assay In vivo DC viability and migration assay

Detailed step-by-step operating procedures for NK cell and CTL degranulation assays

Immunity and Cancer. Doriana Fruci. Lab di Immuno-Oncologia

Lecture 9: T-cell Mediated Immunity

3rd International Conference on Neurology & Therapeutics.

Theiler s Murine Encephalomyelitis Virus-Induced CNS Autoimmunity

What is Autoimmunity?

What is Autoimmunity?

Determinants of Immunogenicity and Tolerance. Abul K. Abbas, MD Department of Pathology University of California San Francisco

Endogenous presentation of self myelin epitopes by CNS-resident APCs in Theiler s virus infected mice

Adaptive immune responses: T cell-mediated immunity

% of live splenocytes. STAT5 deletion. (open shapes) % ROSA + % floxed

The Ying and Yang of IFN-γ in Autoimmunity

Therapeutic effect of baicalin on experimental autoimmune encephalomyelitis. is mediated by SOCS3 regulatory pathway

Induction of antigenspecific. peptide epitopes. University of Bristol

Anti IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis

SUPPLEMENTARY INFORMATION

Lee et al. Molecular Neurodegeneration (2016) 11:54 DOI /s

Naive, memory and regulatory T lymphocytes populations analysis

Immunological Tolerance

SPECIFIC AIMS. II year (1st semester)

The Pennsylvania State University. The Graduate School. The Huck Institutes of Life Sciences REGULATORY ROLE OF NKT CELLS ON EFFECTS OF

Dual Targeting Nanoparticle Stimulates the Immune

Autoimmune Diseases. Betsy Kirchner CNP The Cleveland Clinic

The Adaptive Immune Responses

TCR, MHC and coreceptors

Mucosal Immune System

L-selectin Is Essential for Delivery of Activated CD8 + T Cells to Virus-Infected Organs for Protective Immunity

Antigen Presentation and T Lymphocyte Activation. Abul K. Abbas UCSF. FOCiS

Effector mechanisms of cell-mediated immunity: Properties of effector, memory and regulatory T cells

Supplementary Figure 1. mrna expression of chitinase and chitinase-like protein in splenic immune cells. Each splenic immune cell population was

LESSON 2: THE ADAPTIVE IMMUNITY

Cell-mediated Immunity

Phenotypical and Functional Analysis of Peripheral T Cells in Foxn1 Transgenic Mice: Effects of Aging

Organic dust-induced interleukin-12 production activates T- and natural killer cells

MOLECULAR IMMUNOLOGY Manipulation of immune response Autoimmune diseases & the pathogenic mechanism

Efficient Isolation of Mouse Liver NKT Cells by Perfusion

Supporting Information

Epicutaneous Immunization with Autoantigenic Peptides Induces T Suppressor Cells that Prevent. forms of experimental allergic encephalomyelitis

NEW CONCEPTS IN THE IMMUNOPATHOGENESIS OF MULTIPLE SCLEROSIS

The Adaptive Immune Response. B-cells

Tolerance 2. Regulatory T cells; why tolerance fails. FOCiS. Lecture outline. Regulatory T cells. Regulatory T cells: functions and clinical relevance

Examples of questions for Cellular Immunology/Cellular Biology and Immunology

Effector T Cells and

Supplemental Figure 1. Cell-bound Cetuximab reduces EGFR staining intensity. Blood

T-cell activation T cells migrate to secondary lymphoid tissues where they interact with antigen, antigen-presenting cells, and other lymphocytes:

T-cell activation T cells migrate to secondary lymphoid tissues where they interact with antigen, antigen-presenting cells, and other lymphocytes:

The role of IL-6 in the expression of PD-1 and PDL-1 on CNS cells following infection with Theiler s murine encephalomyelitis virus

Prof. Ibtesam Kamel Afifi Professor of Medical Microbiology & Immunology

Supplementary Figures

SUPPLEMENTARY FIGURE 1

MILLENNIUM REVIEW The application of gene therapy in autoimmune diseases

Dendritic cell subsets and CD4 T cell immunity in Melanoma. Ben Wylie 1 st year PhD Candidate

Supplementary Materials for

NANO 243/CENG 207 Course Use Only

Supplementary Figure 1.

Immune Regulation and Tolerance

Supplementary Materials for

ACTIVATION AND EFFECTOR FUNCTIONS OF CELL-MEDIATED IMMUNITY AND NK CELLS. Choompone Sakonwasun, MD (Hons), FRCPT

Role for CD40 and CD40L Expression in Generating CD8 T Cell Response to Minor Histcompatibility Antigen, H60

Eosinophils are required. for the maintenance of plasma cells in the bone marrow

Tolerance, autoimmunity and the pathogenesis of immunemediated inflammatory diseases. Abul K. Abbas UCSF

SUPPLEMENTARY INFORMATION

La risposta immune all infezione da virus ebola. Chiara Agrati, PhD

Supplemental Information. T Cells Enhance Autoimmunity by Restraining Regulatory T Cell Responses via an Interleukin-23-Dependent Mechanism

Immune Tolerance. Kyeong Cheon Jung. Department of Pathology Seoul National University College of Medicine

This information is current as of November 24, 2018.

IL-17 in health and disease. March 2014 PSO13-C051n

This information is current as of December 7, Harald H. Hofstetter, Carey L. Shive and Thomas G. Forsthuber

1. Overview of Adaptive Immunity

The toll-like receptor 4 ligands Mrp8 and Mrp14 play a critical role in the development of autoreactive CD8 + T cells

Yi Liu 1, 2, 4, Lihui Xu 3, 4, Yiqun Jiang 1, Jianfang Sun 1, 5 and Xianhui He 2, 5. Key Words: LCMV, CD8 T cell, peptide vaccine, phenotype, PD-1

Transcription:

Factors Which Predispose to the Onset of Autoimmune Disease A Senior Honors Thesis Presented in Partial Fulfillment of the Requirements for graduation with distinction in Biology in the College of Biological Sciences of The Ohio State University by Prasad Ravi-Shankar The Ohio State University May 2005 Project Adviser: Dr. Caroline C. Whitacre, Department of Molecular Virology, Immunology and Medical Genetics

Abstract: Multiple sclerosis (MS) is a human demyelinating disease of the central nervous system (CNS). Experimental autoimmune encephalomyelitis (EAE) is a commonly used animal model to study MS. EAE is induced by injecting mice with myelin proteins or peptides combined with immunologic adjuvants. The animals direct an immune response against the injected myelin, which results in attacks against their own CNS tissue. T- helper lymphocytes, bearing the CD4 molecule, have been shown to cause EAE. Clinically, the signs observed in mice with EAE are similar to relapsing-remitting MS (RRMS), in which the disease expresses itself in cycles. Mouse strains typically used are the B10.PL, SJL and C57BL/6, which are susceptible to EAE, but show different patterns of clinical disease. In this study, we compared CD4 lymphocyte levels between males and females in each of these three strains to elucidate any immunologic differences either between the sexes or strains. We used flow cytometry to analyze cell populations on the basis of surface marker combinations. SJL mice have lymphocyte populations composed of 54.5% (females) and 51.8% (males) CD4 cells. These values were found to be 20% higher than the CD4 levels of the other two strains, in both sexes. Within a strain, sex based immunologic differences were minimal (<4%). These findings offer one possible explanation for the increased susceptibility of SJL mice to EAE compared with other strains. The findings also suggest that the sexual dimorphism seen after induction of disease is not due to an immunologic predisposition of either sex. The application of these findings will serve to aid future studies in EAE by providing baseline values. More importantly, these results will also be helpful in delineating different human immunologic states which predispose to the onset of autoimmune disease. (Supported by Dean s Undergraduate Research Fund Award - College of Biological Sciences, Undergraduate Research Scholarship - Colleges of the Arts and Sciences)

Introduction: Multiple sclerosis (MS) is the most common of the demyelinating diseases of the central nervous system (CNS) and affects over 300,000 persons in the United States (Steinman, 1996). In studying MS, the murine animal model of experimental autoimmune encephalomyelitis (EAE) is commonly used. EAE is mediated through the action of CD4+ T-helper cells in response to activation with neuroantigens derived from CNS myelin. Neuroantigens include myelin oligodendrocyte glycoprotein (MOG), proteolipid protein (PLP) and myelin basic protein (MBP). The disease can only be induced in select strains of laboratory mice by injection of neuroantigens and adjuvants. Susceptible strains have been shown to have a bias towards T-helper 1 cytokines (IFN-γ, IL-2) amongst CD4+ T-cells (Duong et al., 1994; Butler et al., 2002). Strains commonly used in studying EAE are the B10.PL (H-2 u ), SJL (H-2 s ) and C57BL/6 (H-2 b ). As with many autoimmune diseases, sexual dimorphism is observed in MS with females showing a greater prevalence of the disease than males (Whitacre, 2001). The disease presents in various clinical forms including relapsing-remitting MS (RRMS), which is more prevalent in females and primary progressive MS (PPMS), which is more prevalent in males (Lublin and Reingold, 1996). EAE, like MS, shows sexual dimorphism but also differences in disease course depending on the strain selected (Papenfuss et al., 2004). The SJL strain exhibits a relapsing-remitting disease pattern similar to RRMS and is more severe in females. The B10.PL shows a disease pattern similar to PPMS with males showing greater disease severity than females while the C57BL/6 strain shows progressive disease with no sex differences (Papenfuss et al., 2004) (Fig.1).

The purpose of this study is to elaborate on these findings by comparing naïve mice for strain and sex differences in order to discern which cell populations predispose a strain/sex to a particular pattern of autoimmune disease. We compared the cell populations in lymph nodes and spleens of naïve SJL, B10.PL and C57BL/6 male and female mice using flow cytometry. Our results indicate that prior to immunization for EAE, there are no sex differences in T-cell populations, nor are differences observed in naïve splenocyte populations. However, basal levels of CD4+ cells are higher in the lymph nodes of the SJL strain relative to the B10.PL and C57BL/6 strains, while immuno-regulatory cell populations are unchanged across strains. Clinical score Clinical score Clinical scores Clinical scores SJL Immunized SJL with Immunized PLP139-151 with PLP (HSLGKWLGHPDKF) 139-151 2 1.5 1 0.5 0 1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 41 43 45 47 Days C57BL/6 35-55 C57BL/6 Immunized with MOG 35-55 4 3 2 1 0 1 4 7 10 13 16 19 22 25 28 31 34 37 40 43 46 49 52 55 58 61 Days Males Females Males Females Figure1 Representative graphs of disease course of SJL, C57BL/6 and B10.PL strains upon induction of EAE. (Papenfuss TL, Rogers CJ, Gienapp I, Valo J, McClain M, Damico N, Song FS, Whitacre CC. Sex differences in experimental autoimmune encephalomyelitis in multiple murine strains. J Neuroimmunol, 150:59-69, 2004.) B10.PL B10.PL Immunized Immunizations with MBP Clinical score Clinical scores 4 3 2 1 0 1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 Days Males Females

Methods/Materials: Mice: Male and female B10.PL (H-2 u ), SJL (H-2 s ) and C57BL/6 (H-2 b ) mice, between 5-9 weeks of age were purchased from Jackson Laboratories (Bar Harbor, ME). Mice were housed 5 per cage and were allowed an acclimation period before experimental use. Isolation of lymph node and spleen: Naïve male and female mice of each strain were sacrificed. Spleens and lymph nodes were harvested and single cell suspensions were prepared for analysis using flow cytometry. Flow Cytometry: Single-cell suspensions were obtained from spleen and lymph nodes and stained using fluorescein isothiocyanate- (FITC), phycoerythrin- (PE) and allophycocyanin- (APC) conjugated antibodies. Staining was carried out as follows: CD4, CD11b, CD19 markers were identified using FITC-conjugated mouse antibodies (mab); CD62L, CD28, CD69, CD8, B220, CD80 markers were identified using PE-conjugated mab; CD25, CD3, CD11c were labelled with APC-conjugated mab (Table 1). Isotype controls were matched for florochrome to control for non-specific binding. Cell suspensions (10 6 cells per tube) were incubated with labelled mab in RPMI medium containing 5% serum for 40 minutes at 4 C. After incubation, cell suspensions were washed and fixed with 1% para-formaldehyde. Stained cells were analyzed on a flow cytometer (FACS Calibur, Becton-Dickinson, San Jose, CA) 24 hours later. All antibodies were purchased from Pharmingen.

Marker CD3 CD4 CD8 CD62L CD25 CD69 CD28 CD19 CD11b CD11c B220 CD80 Description Pan T-cell marker T-helper cells cytotoxic T-cells naïve marker, homing receptor for lymph nodes α-chain of IL-2 receptor, found on activated and regulatory T- cells activation marker costimulatory molecule on T-cells B-cell marker macrophage marker dendritic cell marker B-cell and plasmacytoid dendritic cell marker costimulatory molecule on antigen presenting cells Table 1 Description of cell surface markers. Statistical Analysis: Error bars on graphs represent the standard error of the mean. A one-way ANOVA followed by the Newman-Keuls Multiple Comparison Test was used in determining statistical significance between strains.

Results: 1. Lymph node CD4 levels are elevated in the SJL strain As can be seen in Table 2, lymph node CD4 levels are higher in both male and female SJL mice, compared to levels in B10.PL and C57BL/6 strains. The SJL strain also has a greater percentage of CD3+ cells. Thus, the SJL strain has an increased level of all T-cells, including the CD4+ T-helper cells, which mediate EAE. Interestingly, the SJL strain shows a lower proportion of cells bearing the CD19 marker which is specific for B- cells. A graphical representation of the data can be seen in Fig. 2. The differences between the strains were only seen in lymph nodes and not in the spleen (data not shown). Also, no differences were seen in populations of T-regulatory cells (bearing CD25), dendritic cells or macrophages (data not shown). Strain CD4 CD8 CD3 CD19 SJL (F) 53.97** 32.03 84.96* 2.17** SJL (M) 52.16** 31.86 84.46* 2.93** C57 (F) 34.07 26.52 61.36 8.45 C57 (M) 33.09 25.54 62.12 9.62 B10 (F) 31.93 20.89 49.85 10.62 B10 (M) 32.59 22.43 56.38 13.97* 2. Differences are not seen between sexes Table 2 The SJL strain shows statistically significant i percentage of CD4+ and CD3+ cell populatio males and females. The SJL strain has a statist significant decrease relative to the other two st CD19+ cells. (n=4 for CD4, n=2 for all other markers) * denotes p <.05 ** denotes p <.001 * denotes p <.01 (increase in B10.PL male ov female and C57BL/6 male)) While clear differences can be seen between the sexes when noting the clinical disease pattern (Fig. 1), no significant differences were noted in T-cell phenotypes between the sexes (Fig. 2). As EAE is mediated through the action of T-cells, this suggests that the sexual dimorphism seen during disease is due to factors that occur after immunization for EAE. However, it should be noted that greater percentages of CD19+ cells were seen in B10.PL males compared to females.

Percent Expressi Percent Expression 100 90 80 70 60 50 40 30 20 10 0 Comparison Comparison of cell surface of cell markers surface in markers lymph nodes in of naïve lymph nodes of mice naïve mice ** * ** * ** * CD4 CD8 CD3 CD19 * SJL Female SJL Male C57 Female C57 Male B10 Female B10 Male Figure 2 Levels of CD4+ (T-helper cells), CD8+ (cytotoxic T-cells), CD3+ (T-cells) and CD19+ (B-cells) populations in lymph nodes of SJL, C57BL/6 and B10.PL mice. * denotes significant difference between SJL and C57BL/6 (Females and Males) ** denotes significant difference between SJL and B10.PL (Females and Males) * denotes significant difference between B10.PL male and B10.PL female or C57BL/6 male

Discussion: Naïve male and female mice of the SJL strain have significantly greater numbers of CD3+ and CD4+ lymph node cells and fewer lymph node B-cells relative to mice of the C57BL/6 and B10.PL (B cells only) strains. No sex differences are seen in lymph node or spleen cell populations of naïve mice from the three strains. The differences we observed in the SJL strain can be explained in part by some anomalies reported for the strain. The SJL strain has a reduced repertoire of T-cell receptors (TcR), as well as a deficiency in CD4+, NK1.1+ T-cells which produce the immunosuppressive cytokine IL-4 (Yoshimoto et al., 1995). However, within this reduced pool of receptor specificity, there is an increase in T-cells which recognize the neuroantigen peptide PLP (139-151), used to induce EAE (Anderson et al., 2000). The present findings can be explained in the context of these factors. Due to the reduced repertoire of T-cell types, our hypothesis is that there is an overcompensation of CD4+ cells to counter balance the loss in receptor diversity. A similar homeostatic mechanism may also account for the comparative decrease in B-cells which corresponds to an increase in T-cells. It has been shown that the SJL strain develops EAE and still exhibits sexual dimorphism, without the use of the adjuvant pertussis toxin (PT) (Papenfuss et al., 2004). We speculate that because of the increase in CD4+ cells, the SJL strain is susceptible to disease without the need for PT to amplify the immune response. The cytokine IL-10 has been suggested as a mechanism that protects the SJL from spontaneous EAE (Anderson et al., 2004).

B10.PL and C57BL/6 strains present few differences in the naïve state. This can be linked to their clinical pattern by noting that these strains show few periods of relapse and remission during their disease course. Therefore, the increased CD4+ populations seen in the SJL strain may play a role in the relapsing-remitting disease pattern observed for this mouse. In this study, we have used three highly inbred mouse strains. We view these mouse strains as examples of individual human responses, with the SJL representing an individual highly susceptible to autoimmunity. The implications of this study aid in designing a model which could be used to analyze susceptible individuals and to predict their likely disease course for autoimmune disease. These findings suggest that individuals with increased numbers of T-cells could proceed along a RRMS disease course, similar to the SJL strain. Susceptible individuals with more normal T-cell numbers may demonstrate a disease pattern with less fluctuation, such as PPMS, as seen in the B10.PL and C57BL/6 strains.

Acknowledgements: We would like to thank the members of the Whitacre Lab (Melanie A. McClain, Ingrid Gienapp, Tracey Papenfuss, Nicole Powell, Fei Song, Todd Shawler, NaTosha Gatson, Caroline C. Whitacre) for their support and guidance in this undertaking. This thesis was supported by grants from Dean s Undergraduate Research Fund Award - College of Biological Sciences & Undergraduate Research Scholarship - Colleges of the Arts and Sciences. References: Anderson, A.C., Nicholson, L.B., Legge, K.L., Turchin, V., Zaghouani, H., Kuchroo, V.K., 2000. High frequency of autoreactive myelin proteolipid protein-specific T Cells in the periphery of naïve mice: mechanisms of selection of the self-reactive repertoire. J. Exp. Med. 191, 761-770. Anderson, A.C., Reddy, J., Nazareno, R., Sobel, R.A., Nicholson, L.B., Kuchroo, V.K., 2004. IL-10 plays an important role in the homeostatic regulation of the autoreactive repertoire in naive mice. J. Immunol. 173, 828-834. Butler, N.S., Monick, M.M., Yarovinsky, T.O., Powers, L.S., Hunninghake, G.W., 2002. Altered IL-4 mrna stability correlates with Th1 and Th2 bias and susceptibility to hypersensitivity pneumonitis in two inbred strains of mice. J. Immunol. 164, 3420-3425. Duong, T.T., Finkelman, F.D., Singh, B., Strejan, G.H., 1994. Effect of anti-interferongamma monoclonal antibody treatment on the development of experimental allergic encephalomyelitis in resistant mouse strains. J. Neuroimmunol. 53, 101-107. Lublin, F.D., Reingold, S.C., 1996. Defining the clinical course of multiple sclerosis: results of an international survey, national multiple sclerosis society (USA) advisory committee on clinical trials of new agents in multiple sclerosis. Neurology 46, 907-911.

Papenfuss T.L., Rogers C.J., Gienapp I., Valo J., McClain M., Damico N., Song F.S., Whitacre C.C., 2004. Sex differences in experimental autoimmune encephalomyelitis in multiple murine strains. J Neuroimmunol, 150, 59-69. Steinman, L., 1996. Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system. Cell 85, 299-302. Whitacre, C.C., 2001. Sex differences in autoimmune disease. Nat. Immunol. 2, 777-780. Yoshimoto, T., Bendelac, A., Hu-Li, J., Paul, W.E., 1995. Defective IgE production by SJL mice is linked to the absence of CD4+, NK1.1+ T cells that promptly produce interleukin 4. Proc. Natl. Acad. Sci. U.S.A. 92, 11931-11934.